A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease caused by pathogenic variations in the DMD gene. There is a need for robust DMD biomarkers for diagnostic screening and to aid therapy monitoring. Creatine kinase, to date, is the only routinely used blood biomarker for DMD, although...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Rachele, Johansson, Camilla, Heywood, Wendy, Vinette, Heloise, Jensen, Gabriella, Tegel, Hanna, Jiménez-Requena, Albert, Torelli, Silvia, Al-Khalili Szigyarto, Cristina, Ferlini, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049465/
https://www.ncbi.nlm.nih.gov/pubmed/36982290
http://dx.doi.org/10.3390/ijms24065215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049465/
https://www.ncbi.nlm.nih.gov/pubmed/36982290
http://dx.doi.org/10.3390/ijms24065215

Ejemplares similares